Ischemic stroke associated with COVID-19: a systematic review and meta-analysis

被引:73
作者
Luo, Wenzhang [1 ]
Liu, Xiang [1 ]
Bao, Kunyang [1 ]
Huang, Changren [1 ,2 ,3 ,4 ]
机构
[1] Southwest Med Univ, Dept Neurosurg, Affiliated Hosp, 25 Taiping St, Luzhou 646000, Sichuan, Peoples R China
[2] Neurosurg Clin Res Ctr Sichuan Prov, Luzhou, Peoples R China
[3] Southwest Med Univ, Academician Expert Workstn Sichuan Prov, Affiliated Hosp, Luzhou, Peoples R China
[4] Southwest Med Univ, Lab Neurol Dis & Brain Funct, Affiliated Hosp, Luzhou, Peoples R China
关键词
Ischemic stroke; COVID-19; SARS-CoV-2; Clinical characteristics; CLINICAL CHARACTERISTICS; RISK; ARTERIAL; COMPLICATIONS; PREVENTION; PNEUMONIA; INFECTION;
D O I
10.1007/s00415-021-10837-7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Coronavirus disease 2019 (COVID-19), a contagious infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread across the world. Apart from respiratory complications, an increasing number of patients with ischemic stroke have been reporting. Objective This systematic review and meta-analysis aims to explore the characteristics of ischemic stroke after SARS-CoV-2 infection, and provides valuable reference materials for subsequent clinical treatment. Materials and methods PubMed, Web of Science, and Ovid-Embase databases were searched up to 24th March 2021. We utilized the search strategy of medical subject headings combined with entry terms to search all related literatures. All studies identified with the electronic and manual searches were listed by citation, title, authors, and abstract. Only studies involving patients with COVID-19-related stroke were eligible. The references of included studies were also manually screened. Results The meta-analysis was conducted following the PRISMA and MOOSE reporting guidelines. Bias risk was assessed using the Newcastle-Ottawa Scale (NOS). Ten articles, including 26,691 participants and 280 patients with ischemic stroke and COVID-19, were selected. The pooled prevalence of ischemic stroke in COVID-19 was 2% (95% CI 1-2%; p < 0.01). The pooled proportions of hypertension, hyperlipidemia and diabetes in COVID-19-related ischemic stroke was 66% (95% CI 51-81%; p < 0.01), 48% (95% CI 19-76%; p < 0.01) and 40% (95% CI 29-51%; p < 0.01), respectively. Notably, the pooled proportions of female was 36% (95% CI 21-50%; p < 0.01) in patients with COVID-19 and stroke. In addition, in TOAST classification, cryptogenic stroke subtype was associated with a high trend, and its pooled proportion was 35% (95% CI 12-59%; p < 0.01). Conclusion Ischemic stroke caused by COVID-19 has its own unique clinical features. Although common high-risk factors can also be observed, its importance may have changed. The major inflammatory storm of COVID-19 is more likely to occur in male patients. The increase in the proportion of cryptogenic stroke has also made stroke related to COVID-19 complicated.
引用
收藏
页码:1731 / 1740
页数:10
相关论文
共 62 条
  • [1] CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL
    ADAMS, HP
    BENDIXEN, BH
    KAPPELLE, LJ
    BILLER, J
    LOVE, BB
    GORDON, DL
    MARSH, EE
    KASE, CS
    WOLF, PA
    BABIKIAN, VL
    LICATAGEHR, EE
    ALLEN, N
    BRASS, LM
    FAYAD, PB
    PAVALKIS, FJ
    WEINBERGER, JM
    TUHRIM, S
    RUDOLPH, SH
    HOROWITZ, DR
    BITTON, A
    MOHR, JP
    SACCO, RL
    CLAVIJO, M
    ROSENBAUM, DM
    SPARR, SA
    KATZ, P
    KLONOWSKI, E
    CULEBRAS, A
    CAREY, G
    MARTIR, NI
    FICARRA, C
    HOGAN, EL
    CARTER, T
    GURECKI, P
    MUNTZ, BK
    RAMIREZLASSEPAS, M
    TULLOCH, JW
    QUINONES, MR
    MENDEZ, M
    ZHANG, SM
    ALA, T
    JOHNSTON, KC
    ANDERSON, DC
    TARREL, RM
    NANCE, MA
    BUDLIE, SR
    DIERICH, M
    HELGASON, CM
    HIER, DB
    SHAPIRO, RA
    [J]. STROKE, 1993, 24 (01) : 35 - 41
  • [2] Gender differences and woman-specific trends in acute stroke: Results from a hospital-based registry (1986-2009)
    Arboix, Adria
    Cartanya, Anna
    Lowak, Michael
    Garcia-Eroles, Luis
    Parra, Olga
    Oliveres, Montserrat
    Massons, Joan
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2014, 127 : 19 - 24
  • [3] Advancements in understanding the mechanisms of symptomatic lacunar ischemic stroke: translation of knowledge to prevention strategies
    Arboix, Adria
    Blanco-Rojas, Lorena
    Lluis Marti-Vilalta, Josep
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2014, 14 (03) : 261 - 276
  • [4] Behzadnia H., 2020, ROMANIAN J NEUROL, V19, P166, DOI [10.37897/RJN.2020.3.5, DOI 10.37897/RJN.2020.3.5]
  • [5] HIV-Associated Venous Thromboembolism
    Bibas, Michele
    Biava, Gianluigi
    Antinori, Andrea
    [J]. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2011, 3 (01):
  • [6] Risk of Cardiovascular Ischemic Events After Surgical Castration and Gonadotropin-Releasing Hormone Agonist Therapy for Prostate Cancer: A Nationwide Cohort Study
    Chen, Dong-Yi
    See, Lai-Chu
    Liu, Jia-Rou
    Chuang, Cheng-Keng
    Pang, See-Tong
    Hsieh, I-Chang
    Wen, Ming-Shien
    Chen, Tien-Hsing
    Lin, Yung-Chang
    Liaw, Chuang-Chi
    Hsu, Cheng-Lung
    Chang, John Wen-Cheng
    Kuo, Chang-Fu
    Huang, Wen-Kuan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (32) : 3697 - +
  • [7] Classifying Ischemic Stroke, from TOAST to CISS
    Chen, Pei-Hao
    Gao, Shan
    Wang, Yong-Jun
    Xu, An-Ding
    Li, Yan-Sheng
    Wang, David
    [J]. CNS NEUROSCIENCE & THERAPEUTICS, 2012, 18 (06) : 452 - 456
  • [8] The importance of comorbidities in ischemic stroke: Impact of hypertension on the cerebral circulation
    Cipolla, Marilyn J.
    Liebeskind, David S.
    Chan, Siu-Lung
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2018, 38 (12) : 2129 - 2149
  • [9] Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage
    Diener, Hans-Christoph
    Hankey, Graeme J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (15) : 1804 - 1818
  • [10] IL-17A promotes the formation of deep vein thrombosis in a mouse model
    Ding, Peiwu
    Zhang, Shaoshao
    Yu, Miao
    Feng, Yuqian
    Long, Qi
    Yang, Huimin
    Li, Jingdong
    Wang, Min
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 57 : 132 - 138